John A. Dunn

4.1k total citations · 1 hit paper
63 papers, 3.2k citations indexed

About

John A. Dunn is a scholar working on Molecular Biology, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, John A. Dunn has authored 63 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Clinical Biochemistry and 10 papers in Infectious Diseases. Recurrent topics in John A. Dunn's work include Advanced Glycation End Products research (10 papers), HIV/AIDS drug development and treatment (6 papers) and Biochemical effects in animals (4 papers). John A. Dunn is often cited by papers focused on Advanced Glycation End Products research (10 papers), HIV/AIDS drug development and treatment (6 papers) and Biochemical effects in animals (4 papers). John A. Dunn collaborates with scholars based in United States and United Kingdom. John A. Dunn's co-authors include John Baynes, Timothy J. Lyons, D G Dyer, K. Bailie, Suzanne R. Thorpe, S R Thorpe, David R. McCance, David R. McCance, Suzanne R. Thorpe and Jeffrey S. Patrick and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Biochemistry.

In The Last Decade

John A. Dunn

57 papers receiving 3.1k citations

Hit Papers

Accumulation of Maillard reaction products in skin collag... 1993 2026 2004 2015 1993 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Dunn United States 23 1.7k 844 783 655 332 63 3.2k
Lucy A. Hunsaker United States 31 484 0.3× 264 0.3× 1.3k 1.6× 421 0.6× 264 0.8× 51 3.3k
Azeddine Ibrahimi Morocco 27 255 0.1× 341 0.4× 2.0k 2.6× 935 1.4× 127 0.4× 130 3.6k
Roberto Bei Italy 40 315 0.2× 355 0.4× 2.0k 2.5× 325 0.5× 325 1.0× 154 5.1k
Clementina Mesaros United States 30 180 0.1× 401 0.5× 1.6k 2.1× 516 0.8× 117 0.4× 129 3.4k
Werner Kramer Germany 42 164 0.1× 556 0.7× 1.7k 2.2× 480 0.7× 136 0.4× 115 4.8k
Leszek Wojnowski Germany 39 119 0.1× 576 0.7× 2.5k 3.2× 329 0.5× 421 1.3× 93 6.1k
Zafar Rasheed Saudi Arabia 29 256 0.2× 176 0.2× 914 1.2× 247 0.4× 176 0.5× 113 3.0k
James Pitt Australia 31 1.1k 0.7× 166 0.2× 1.7k 2.1× 317 0.5× 83 0.3× 104 2.8k
S. Subramanian India 25 154 0.1× 416 0.5× 665 0.8× 358 0.5× 101 0.3× 69 2.1k

Countries citing papers authored by John A. Dunn

Since Specialization
Citations

This map shows the geographic impact of John A. Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Dunn more than expected).

Fields of papers citing papers by John A. Dunn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Dunn. The network helps show where John A. Dunn may publish in the future.

Co-authorship network of co-authors of John A. Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Dunn. A scholar is included among the top collaborators of John A. Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Dunn. John A. Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Guzmán, Bryan B., Amanda P. Schauer, John A. Dunn, Mackenzie L. Cottrell, & Craig Sykes. (2021). A quantitative LC–MS/MS method for the determination of tissue brincidofovir and cidofovir diphosphate in a MuPyV‐infected mouse model. Biomedical Chromatography. 35(5). e5061–e5061.
3.
Wire, Mary Beth, et al.. (2017). Pharmacokinetics (PK) and Safety of Intravenous (IV) Brincidofovir (BCV) in Healthy Adult Subjects. Open Forum Infectious Diseases. 4(suppl_1). S311–S311. 8 indexed citations
4.
Grossi, Irma M., et al.. (2017). Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits. Antiviral Research. 143. 278–286. 34 indexed citations
5.
Summerfield, Scott, Christopher A. Evans, Neil Spooner, et al.. (2014). Integrating Internal and External Bioanalytical Support to Deliver A Diversified Pharmaceutical Portfolio. Bioanalysis. 6(10). 1311–1319. 8 indexed citations
6.
Cohen, Myron S., et al.. (2000). Simultaneous determination of lamivudine and zidovudine concentrations in human seminal plasma using high-performance liquid chromatography and tandem mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 742(1). 173–183. 64 indexed citations
7.
Wring, Stephen A., et al.. (2000). Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 22(6). 967–983. 99 indexed citations
8.
Dunn, John A.. (1998). Planning Is Not a Management Substitute.. Planning for higher education. 26(4). 10–18. 1 indexed citations
9.
Dunn, John A. & Paul Savina. (1996). Validation of a high-performance liquid chromatographic-mass spectrometric method for the measurement of 5-chloro-2′,3′-dideoxy-3′-fluorouridine (935U83) in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 686(2). 241–248. 4 indexed citations
10.
Dunn, John A., et al.. (1994). The Whole Cost of Libraries.. Library trends. 42(3). 564–578. 4 indexed citations
11.
McCance, David R., D G Dyer, John A. Dunn, et al.. (1993). Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.. Journal of Clinical Investigation. 91(6). 2470–2478. 367 indexed citations
12.
Dunn, John A.. (1993). Long-Term Tuition Policy: What Happens When Tuition Rises Faster than Ability to Pay?.. 1(3). 6–10. 1 indexed citations
13.
Dyer, D G, John A. Dunn, Suzanne R. Thorpe, et al.. (1992). Accumulation of Maillard Reaction Products in Skin Collagen in Diabetes and Aginga. Annals of the New York Academy of Sciences. 663(1). 421–422. 26 indexed citations
14.
Lyons, Timothy J., K. Bailie, D G Dyer, John A. Dunn, & John Baynes. (1991). Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus.. Journal of Clinical Investigation. 87(6). 1910–1915. 94 indexed citations
15.
Dunn, John A.. (1991). How Colleges Should Handle Their Endowment.. Planning for higher education. 19(3). 32–37. 2 indexed citations
16.
Dunn, John A., Mahtab U. Ahmed, Martha H. Murtiashaw, et al.. (1990). Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N.epsilon.-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. Biochemistry. 29(49). 10964–10970. 147 indexed citations
17.
Dunn, John A.. (1989). Fund Raising's Top 100.. Currents. 15(8). 50–55. 2 indexed citations
18.
Kennedy, Donald J., et al.. (1984). Effects of Escherichia coli heat-stable enterotoxin STb on intestines of mice, rats, rabbits, and piglets. Infection and Immunity. 46(3). 639–643. 66 indexed citations
19.
Dunn, John A., et al.. (1983). Look Into My Crystal Cathode Ray Tube: Computer Models Make Annual Giving Predictions Easy.. 9(3). 38–42. 1 indexed citations
20.
Greenberg, Richard N., John A. Dunn, & Richard L. Guerrant. (1983). Reduction of the secretory response to Escherichia coli heat-stable enterotoxin by thiol and disulfide compounds. Infection and Immunity. 41(1). 174–180. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026